<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04311437</url>
  </required_header>
  <id_info>
    <org_study_id>CMRPG8K0461</org_study_id>
    <nct_id>NCT04311437</nct_id>
  </id_info>
  <brief_title>Effect of Self-acupressure on Middle Ear Barotrauma Associated With Hyperbaric Oxygen Therapy</brief_title>
  <official_title>Effect of Self-acupressure on Middle Ear Barotrauma Associated With Hyperbaric Oxygen Therapy: a Nonrandomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chang Gung Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chang Gung Memorial Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Middle ear barotrauma (MEB) is the most common complication during hyperbaric oxygen therapy
      (HBOT). Though Valsalva and Toynbee maneuvers have been proposed to prevent MEB, still some
      patients discontinue HBOT due to severe otalgia, hemorrhage or perforation of tympanic
      membrane associated with HBOT. Currently, there is no optimal prophylactic management for MEB
      associated with HBOT. The aim of this protocol is to investigate the efficacy of
      self-acupressure therapy on MEB associated with HBOT.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2020</start_date>
  <completion_date type="Anticipated">July 2022</completion_date>
  <primary_completion_date type="Anticipated">February 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Modified Teed Classification</measure>
    <time_frame>1 month</time_frame>
    <description>The Modified Teed Classification, with grades from 0 to 5: Grade 0 indicates symptoms with no ontological signs of trauma; Grade 1 indicates injection of the tympanic membrane; Grade 2 indicates Grade 1 plus injection plus mild hemorrhage within the tympanic membrane; Grade 3 indicates gross hemorrhage within the tympanic membrane; Grade 4 indicates free blood in the middle ear as evidenced by blueness and bulging; and Grade 5 indicates perforation of the tympanic membrane.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Symptoms of MEB</measure>
    <time_frame>1 month</time_frame>
    <description>Record the symptoms of MEB including feeling pressure in the ears, ear pain, headache, dizziness, vertigo, tinnitus and hearing loss. Each symptom is estimated using a 10-cm visual analogue scale with anchor points of 0 (no discomfort) and 10 (maximum discomfort).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall ear discomfort levels</measure>
    <time_frame>1 month</time_frame>
    <description>Estimated using a 10-cm visual analogue scale with anchor points of 0 (no discomfort) and 10 (maximum discomfort).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">152</enrollment>
  <condition>Hyperbaric Oxygen Therapy</condition>
  <condition>Middle Ear Barotrauma</condition>
  <arm_group>
    <arm_group_label>Self-acupressure group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The subjects in experimental group will undergo additional self-acupressure therapy in addition to Valsalva and Toynbee maneuvers before the first HBOT. The acupoints used are TE17 (Yifeng, 翳風), TE21 (Ermen, 耳門), SI19 (Tinggong, 聽宮), GB2 (Tinghui, 聽會).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The subjects in control group will receive Valsalva and Toynbee maneuvers alone.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Self-acupressure therapy</intervention_name>
    <description>The self-acupressure therapy is as follows: Patients are in sitting position, applied firm pressure (3-5 kg of pressure) with the fingertips in a circular motion at a speed of two circles per second for a duration of one min per acupoint. A 1-2-s rest is applied after each ten circles. The complete process lasts for about 5 min.</description>
    <arm_group_label>Self-acupressure group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Combined Valsalva and Toynbee maneuvers</intervention_name>
    <description>Valsalva maneuver: blowing against a closed mouth and nostrils, increasing the middle ear pressure. Toynbee maneuver: swallowing while the mouth and nostrils are closed, decreasing the middle ear pressure.</description>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_label>Self-acupressure group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged 20 years or order receiving the first HBOT

          -  Alert consciousness

        Exclusion Criteria:

          -  Pregnancy

          -  Having any acute disorder of the ears or upper respiratory tract

          -  Having evidence of neurologic dysfunction precluding them from making an informed
             decision

          -  Having a tracheostomy or endotracheal intubation

          -  Having received a myringotomy, tympanoplasty, mastoidectomy or tympanostomy tube
             placement.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chun-Ting Liu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Chinese Medicine, Kaohsiung Chang Gung Memorial Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chun-Ting Liu, MD</last_name>
    <phone>+886-7-7317123</phone>
    <phone_ext>2334</phone_ext>
    <email>juntin0214@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Kaohsiung Chang Gung Memorial Hospital</name>
      <address>
        <city>Kaohsiung</city>
        <zip>833</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chun-Ting Liu, MD</last_name>
      <phone>+886-7-7317123</phone>
      <phone_ext>2334</phone_ext>
      <email>juntin0214@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 16, 2020</study_first_submitted>
  <study_first_submitted_qc>March 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 17, 2020</study_first_posted>
  <last_update_submitted>March 22, 2020</last_update_submitted>
  <last_update_submitted_qc>March 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hyperbaric oxygen therapy</keyword>
  <keyword>Middle ear barotrauma</keyword>
  <keyword>Acupressure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Barotrauma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

